BusinessCyclacel’s Second-Generation CDK2/9 Inhibitor, CYC065, is an Effective Inducer of Cell Death in B-cell Lymphoma and Synergizes With Bcl-2 or BET InhibitorsBy Nasdaq OMXApr 18, 2016, 1:00 PM UTC
